Author:
Ovčarenko Sergej,Danilova Viktorija,Kalnicka Violeta
Abstract
Objective. The development of clinical and laboratory criteria for diagnosis of systemic inflammatory response significantly expanded the use of this concept in clinical practice. The correlation between the levels of antiinflammatory and pro-inflammatory cytokines is an important aspect in regulation of systemic inflammatory response. Treatment of systemic inflammatory response includes three main links: effect on the levels of endotoxin, cytokines and the state of endothelium. Currently there is no unified approach to the solution of this problem, which determines the relevance of the topic. The aim of the research was to study the efficacy of the deproteinized hemodialysate from the newborn calf blood in systemic inflammatory response in newborns with severe asphyxia at birth. Methods. The study involved examination of 16 newborns with severe asphyxia at birth, who received a drug as part of standard therapy from the first day of the disease at a dose of 0.5 ml/kg. The study implied a follow-up assessment of interleukin-4 and interleukin-6 levels. Sign test and Wilcoxon test were used for paired samples; Kolmogorov-Smirnov and Mann-Whitney tests were used for non-paired samples. To investigate the influence of the independent variable on the dependent variable we used Kruskal-Wallis and median tests as nonparametric analogs of the variance analysis. Results. Deproteinized hemodialysate derived from the newborn calf blood is a vasoprotector and is a combination of a number of physiologically active ingredients. They stimulate oxygen utilization by tissues in hypoxic conditions, enhancing glucose transport through biological membranes, intensifying intracellular adenosine triphosphate synthesis, and increasing the proportion of aerobic glycolysis. Conclusion. Administration of deproteinized hemodialysate from the newborn calf blood in the treatment of systemic inflammatory response in newborns with severe asphyxia at birth exerts influence on biochemical pattern of systemic inflammatory response by reducing inflammation and reducing synthesis of cytokines.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference11 articles.
1. iarustovskiĭ MB, abramian MV, krotenko nP, et al. Experience of using endotoxin selective adsorption in patients with severe sepsis after open-heart surgery. anesteziol reanimatol 2014; (3): 39-46. (in russian);
2. kozlov ia, Poptsov Vn, alferov aV. Methylene blue as an inhibitor of endogenous nitric oxide overproduction in the correction of postperfusion vascular insufficiency. annals of Critical Care 2002; (2): 7-12. (in russian);
3. khubutiia MSh, abakumov MM, aleksandrova iV, et al. Selective adsorption of endotoxin in the complex treatment of patients with severe sepsis. anesteziol reanimatol 2010; (5): 65-9. (in russian);
4. Chukanova Ei, a n Bogolepova an. Perspectives of the use of solcoseryl in the therapy of ischemic encephalopathy. Zh nevrol Psikhiatr im S S korsakova 2007; Suppl 21: 57-64. (in russian);
5. Opal SM. the host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. int J Med Microbiol 2007; 297: 365-77;